Sartorius Stedim Biotech S.A.'s latest marketcap:
As of 07/04/2025, Sartorius Stedim Biotech S.A.'s market capitalization has reached $23.37 B. According to our data, Sartorius Stedim Biotech S.A. is the 939th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 23.37 B |
| Revenue (ttm) | 3.36 B |
| Net Income (ttm) | 240.56 M |
| Shares Out | 97.3 M |
| EPS (ttm) | 2.49 |
| Forward PE | 43.52 |
| Ex-Dividend Date | 04/02/2025 |
| Earnings Date | 07/22/2025 |
Sartorius Stedim Biotech S.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | €23.37 B | 7.83% | 939 |
| 12/31/2024 | €18.36 B | -16.81% | 987 |
| 12/29/2023 | €22.07 B | -20.84% | 742 |
| 12/30/2022 | €27.88 B | -37.29% | 561 |
| 12/31/2021 | €44.47 B | 65.66% | 373 |
| 12/31/2020 | €26.84 B | 97.16% | 536 |
| 12/31/2019 | €13.62 B | 69.09% | 908 |
| 12/31/2018 | €8.05 B | 44.88% | 1205 |
| 12/29/2017 | €5.56 B | 0.53% | 1864 |
| 12/30/2016 | €5.53 B | 1.79% | 1686 |
Company Profile
About Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. is a global leader in providing instruments and consumables for the biopharmaceutical industry. The company supports manufacturers and research laboratories with innovative solutions for biopharmaceutical production, analysis, and storage.
Key Products & Services
- Cell Culture & Bioprocessing: Cell lines, culture media, bioreactors, and reagents.
- Separation & Purification: Chromatography systems, filtration, and concentration products.
- Storage & Transportation: Solutions for biological intermediates and finished products.
- Fluid Management & Microbiology: Testing instruments, sterility monitoring, and pipette products.
- Analytical Tools: Sensors, biomolecule analysis, and live cell imaging.
- Software Solutions: Lab data management, process automation, and data analytics.
- Water Purification & Weighing: High-purity water systems and precision weighing products.
Industries Served
The company caters to manufacturers of medications, vaccines, food, and chemicals, as well as R&D laboratories worldwide.
Corporate Overview
Founded in 1978 and headquartered in Aubagne, France, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Frequently Asked Questions
-
What is Sartorius Stedim Biotech S.A.'s (EPA-DIM) current market cap?As of 07/04/2025, Sartorius Stedim Biotech S.A. (including the parent company, if applicable) has an estimated market capitalization of $23.37 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sartorius Stedim Biotech S.A. (EPA-DIM) rank globally by market cap?Sartorius Stedim Biotech S.A. global market capitalization ranking is approximately 939 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.